351 related articles for article (PubMed ID: 26321489)
1. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
Hasnat MJ; Rice JE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
[TBL] [Abstract][Full Text] [Related]
3. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.
Pin TW; McCartney L; Lewis J; Waugh MC
Dev Med Child Neurol; 2011 Oct; 53(10):885-95. PubMed ID: 21635230
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial.
Gilmartin R; Bruce D; Storrs BB; Abbott R; Krach L; Ward J; Bloom K; Brooks WH; Johnson DL; Madsen JR; McLaughlin JF; Nadell J
J Child Neurol; 2000 Feb; 15(2):71-7. PubMed ID: 10695888
[TBL] [Abstract][Full Text] [Related]
5. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
6. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
[TBL] [Abstract][Full Text] [Related]
7. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.
Butler C; Campbell S
Dev Med Child Neurol; 2000 Sep; 42(9):634-45. PubMed ID: 11034458
[No Abstract] [Full Text] [Related]
8. Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study.
Bjornson KF; McLaughlin JF; Loeser JD; Nowak-Cooperman KM; Russel M; Bader KA; Desmond SA
Arch Phys Med Rehabil; 2003 Apr; 84(4):500-6. PubMed ID: 12690587
[TBL] [Abstract][Full Text] [Related]
9. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
10. Intrathecal baclofen therapy in children with cerebral palsy.
Brown TR
Arch Phys Med Rehabil; 2003 Apr; 84(4):624; author reply 624. PubMed ID: 12690609
[No Abstract] [Full Text] [Related]
11. Clinical practices in intrathecal baclofen pump implantation in children with cerebral palsy in France.
Mietton C; Nuti C; Dohin B; Bayle B; Fernandez B; Poirot I; Gautheron V; Vuillerot C
Ann Phys Rehabil Med; 2016 Sep; 59(4):282-4. PubMed ID: 27158102
[No Abstract] [Full Text] [Related]
12. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy.
Gerszten PC; Albright AL; Johnstone GF
J Neurosurg; 1998 Jun; 88(6):1009-13. PubMed ID: 9609295
[TBL] [Abstract][Full Text] [Related]
13. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
[TBL] [Abstract][Full Text] [Related]
15. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
; Delgado MR; Hirtz D; Aisen M; Ashwal S; Fehlings DL; McLaughlin J; Morrison LA; Shrader MW; Tilton A; Vargus-Adams J
Neurology; 2010 Jan; 74(4):336-43. PubMed ID: 20101040
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal baclofen for spasticity in cerebral palsy.
Albright AL; Cervi A; Singletary J
JAMA; 1991 Mar; 265(11):1418-22. PubMed ID: 1999883
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
Agarwal S; Patel T; Shah N; Patel BM
Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
19. Is baclofen the least worst option for spasticity management in children?
Brandenburg JE
J Pediatr Rehabil Med; 2023; 16(1):11-17. PubMed ID: 36938744
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic interventions for reducing spasticity in cerebral palsy.
Patel DR; Soyode O
Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
